| Filed On | Filing |
|---|---|
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
–Full-Year 2026 Guidance Raised to Above High End for All Key Financial Metrics |
| 30 Oct 2026 | SCHEDULE 13G |
| 07 Oct 2026 | SCHEDULE 13G/A |
| 08 Sep 2026 | SCHEDULE 13D |
| 03 Sep 2026 |
Form 4: Ernest Opella Finley, Director
Received 6,350 shares as a grant or award |
| 03 Sep 2026 |
Form 3: Ernest Opella Finley, Director
No securities owned |
| 18 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of DirectorsDr. Ernest brings significant value-based care and clinical expertise |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
–Full-Year 2026 Guidance Raised for All Key Financial Metrics |
| 29 Jul 2026 | SCHEDULE 13G/A |
| 13 Jul 2026 |
Form 4: Mountcastle David, EVP & Chief Financial Officer
Sold 21,275 shares ($589K) |
| 09 Jul 2026 | 144 |
| 09 Jul 2026 |
Form 4: Mountcastle David, EVP & Chief Financial Officer
Sold 600 shares ($16.5K) |
| 07 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On July 6, 2026, Shawn Morris resigned from his position as a member of the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) and as a member of the Compliance Committee of the Board, effective immediately. Mr... |
| 07 Jul 2026 |
Form 4: Morris Matthew Shawn, Director
Received 59,037 shares by exercise or conversion ($118K) · Sold 59,037 shares ($1.61M) · Received 53,722 shares by exercise or conversion ($107K) · 1 more |
| 07 Jul 2026 |
Form 4: Mountcastle David, EVP & Chief Financial Officer
Sold 24,734 shares ($680K) |
| 07 Jul 2026 | 144 |
| 02 Jul 2026 | 144 |
| 02 Jul 2026 |
Form 4: Morris Matthew Shawn, Director
Received 52,823 shares by exercise or conversion ($106K) · Sold 52,823 shares ($1.36M) · Received 82,675 shares by exercise or conversion ($165K) · 1 more |
Loading...